Led by Editors Andres Cervantes, Giuseppe Curigliano, Georg Lenz and Rolf Stahel, Cancer Treatment Reviews is one of the latest additions to the ESMO family of journals.
Cancer Treatment Reviews is an international journal that provides state of the art, authoritative review articles to the clinician and researcher to keep them abreast of modern concepts and the latest developments in cancer treatment research.
What type of papers does Cancer Treatment Reviews publish?
The Editors welcome the submission of state of the art, authoritative reviews; evidence-based reviews (using a priori defined selection process to identify key articles from the literature and reviewing them in the form of a structured abstract, evidence summary and commentary); and systematic reviews. Please note that the journal will not accept original articles (including meta-analyses).
Types of contribution
- Comments on Controversy
- Tumour Review
- Anti-tumour Treatment
- New Drugs
- Complications of Treatment
- General and Supportive Care
- Laboratory-Clinic Interface
- Systematic or Meta-analysis Studies
Why publish with Cancer Treatment Reviews?
- Rigorous peer review by noted experts in the field
- Submission to first decision in 1.1 weeks; Submission to final decision in 2 weeks
ESMO members are entitled to receive a 20% discount on the journal's article publication charge for all papers submitted after January 1st 2023. Find out more about joining ESMO